About the journal
Cancer Discovery is a journal published by American Association for Cancer Research in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- American Association for Cancer Research
- ISSN
- 2159-8274 · 2159-8290
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://cancerdiscovery.aacrjournals.org
Index listings
- MEDLINE · 2011-01-01
- PUBMED · 2017-05-05
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 139 days received→accepted — computed from PubMed (n=51)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
8017
Last recorded publication year
2026
h-index
301
i10-index
1822
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 40%
- ORCID iDs in current deposits
- 41%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Cancer Discov
- Source type
- journal
- NLM unique ID (PubMed)
- 101561693
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- CAR-T cell therapy research
- CAR-T cell therapy research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
Show all subjects (50)
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Melanoma and MAPK Pathways
- Melanoma and MAPK Pathways
- Immune cells in cancer
- Immune cells in cancer
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- DNA Repair Mechanisms
- Lung Cancer Research Studies
- DNA Repair Mechanisms
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ